Wolfe Research has released updated readings from its Activist Attractiveness Score and identified a set of companies that rank in the 99th percentile or above within its coverage universe - the level it considers the most exposed to potential shareholder activism.
Top names at extreme vulnerability
The firms Wolfe lists at the very top of its rankings are Globant; Molina Healthcare (NYSE:MOH); Humana (NYSE:HUM); Innospec; Bright Horizons (NYSE:BFAM); Universal Display (NASDAQ:OLED); QUALCOMM (NASDAQ:QCOM); Concentrix; Extreme Networks (NASDAQ:EXTR); Enphase Energy (NASDAQ:ENPH); Landstar System (NASDAQ:LSTR); and Genius Sports.
Where Wolfe draws the line
According to Wolfe Research, companies that place in the 75th percentile or higher on the Activist Attractiveness Score are generally considered more vulnerable to engagement from activist shareholders. Scores that reach the extreme end of the distribution - such as the 99th percentile group cited - are particularly notable within the firm’s framework.
Monitoring changes for inflection points
Beyond static rankings, Wolfe tracks movements in the Activist Attractiveness Score over time to detect potential inflection points. Firms registering the largest recent increases in their scores include HNI Corp; ServiceNow (NYSE:NOW); Armstrong World Industries (NYSE:AWI); Avista Corp (NYSE:AVA); BJ’s Wholesale Club (NYSE:BJ); Public Service Enterprise Group (NYSE:PEG); Ionis Pharmaceuticals (NASDAQ:IONS); and SkyWest Inc (NASDAQ:SKYW).
The firm’s dual approach - highlighting both the highest-scoring companies and those with the steepest recent score increases - is intended to surface where shareholder activism may be most likely or where risk is rising. Wolfe’s published guidance clarifies that percentile thresholds serve as signals of relative vulnerability within its coverage universe.
Note: The information above reflects Wolfe Research’s stated scores and the companies the firm cited; it is limited to the data and conclusions Wolfe reported and does not add additional analysis beyond those disclosures.